- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Advances in Hematology
Volume 2012 (2012), Article ID 924042, 8 pages
Synergistic Effect of Anemia and Red Blood Cells Transfusion on Inflammation and Lung Injury
1Division of Cardiovascular Medicine, The Gill Heart Institute, 741 S. Limestone Street, 252 BBSRB, Lexington, KY 40536-0509, USA
2Medical Service, Lexington VA Medical Center, 1101 Veterans Drive, Lexington, KY 40502, USA
Received 5 March 2012; Accepted 26 June 2012
Academic Editor: Shimon Slavin
Copyright © 2012 Anping Dong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. E. Repine, “Scientific perspectives on adult respiratory distress syndrome,” The Lancet, vol. 339, no. 8791, pp. 466–469, 1992.
- R. Shenkar and E. Abraham, “Hemorrhage induces rapid in vivo activation of CREB and NF-κB in murine intraparenchymal lung mononuclear cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 16, no. 2, pp. 145–152, 1997.
- M. V. Parsey, R. M. Tuder, and E. Abraham, “Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia,” Journal of Immunology, vol. 160, no. 2, pp. 1007–1013, 1998.
- C. E. Chapman, D. Stainsby, H. Jones et al., “Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma,” Transfusion, vol. 49, no. 3, pp. 440–452, 2009.
- A. P. J. Vlaar, M. Straat, and N. P. Juffermans, “The relation between aged blood products and onset of transfusion-related acute lung injury: a review of pre-clinical data,” Clinical Laboratory, vol. 57, no. 3-4, pp. 267–272, 2011.
- J.-P. Tung, J. F. Fraser, M. Nataatmadja et al., “Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI),” Critical Care, vol. 16, no. 1, article R19, 2012.
- C. Bode, S. C. Sensken, U. Peest et al., “Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate,” Journal of Cellular Biochemistry, vol. 109, no. 6, pp. 1232–1243, 2010.
- S. Selim, M. Sunkara, A. K. Salous et al., “Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions,” Clinical Science, vol. 121, no. 12, pp. 565–572, 2011.
- Y. Sadahira, T. Yasuda, T. Yoshino et al., “Impaired splenic erythropoiesis in phlebotomized mice injected with CL2MDP-liposome: an experimental model for studying the role of stromal macrophages in erythropoiesis,” Journal of Leukocyte Biology, vol. 68, no. 4, pp. 464–470, 2000.
- E. Beutler, C. West, and K. G. Blume, “The removal of leukocytes and platelets from whole blood,” Journal of Laboratory and Clinical Medicine, vol. 88, no. 2, pp. 328–333, 1976.
- P. Hänel, P. Andréani, and M. H. Gräler, “Erythrocytes store and release sphingosine 1-phosphate in blood,” FASEB Journal, vol. 21, no. 4, pp. 1202–1209, 2007.
- K. Venkataraman, Y. M. Lee, J. Michaud et al., “Vascular endothelium as a contributor of plasma sphingosine 1-phosphate,” Circulation Research, vol. 102, no. 6, pp. 669–676, 2008.
- S. M. Dudek, J. R. Jacobson, E. T. Chiang et al., “Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate. Roles for cortactin and myosin light chain kinase,” The Journal of Biological Chemistry, vol. 279, no. 23, pp. 24692–24700, 2004.
- J. G. N. Garcia, F. Liu, A. D. Verin et al., “Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement,” Journal of Clinical Investigation, vol. 108, no. 5, pp. 689–701, 2001.
- B. J. McVerry, X. Peng, P. M. Hassoun, S. Sammani, B. A. Simon, and J. G. N. Garcia, “Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 9, pp. 987–993, 2004.
- X. Peng, P. M. Hassoun, S. Sammani et al., “Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 11, pp. 1245–1251, 2004.
- W. S. Szczepaniak, Y. Zhang, S. Hagerty et al., “Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo,” Translational Research, vol. 152, no. 5, pp. 213–224, 2008.
- M. Okazaki, F. Kreisel, S. B. Richardson et al., “Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation,” American Journal of Transplantation, vol. 7, no. 4, pp. 751–758, 2007.
- S. Sammani, L. Moreno-Vinasco, T. Mirzapoiazova et al., “Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 43, no. 4, pp. 394–402, 2010.